Found: 22
Select item for more details and to access through your institution.
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01046-2
- By:
- Publication type:
- Article
Potential value of pre-planned imaging of bone disease in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00880-0
- By:
- Publication type:
- Article
Use of bisphosphonates in multiple myeloma patients in Denmark, 2005–2015.
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 8, p. 4501, doi. 10.1007/s00520-020-05934-8
- By:
- Publication type:
- Article
Validation of the UK myeloma research alliance risk profile, a new clinical prediction model for outcome in patients with newly diagnosed multiple myeloma not eligible for autologous stem cell transplantation; a population‐based study from the Danish national multiple myeloma registry
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 1, p. 119, doi. 10.1111/bjh.16806
- By:
- Publication type:
- Article
The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab‐containing line of therapy.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. E117, doi. 10.1002/ajh.26449
- By:
- Publication type:
- Article
Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 1, p. 34, doi. 10.1111/ejh.13709
- By:
- Publication type:
- Article
The real-world outcomes of multiple myeloma patients treated with daratumumab.
- Published in:
- PLoS ONE, 2021, v. 16, n. 10, p. 1, doi. 10.1371/journal.pone.0258487
- By:
- Publication type:
- Article
The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population-based study.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 7, p. 1807, doi. 10.1002/cam4.1128
- By:
- Publication type:
- Article
Smoldering multiple myeloma risk factors for progression: a Danish population-based cohort study.
- Published in:
- European Journal of Haematology, 2016, v. 97, n. 3, p. 303, doi. 10.1111/ejh.12728
- By:
- Publication type:
- Article
Self-assessment in cancer patients referred to palliative care.
- Published in:
- Cancer (0008543X), 2002, v. 94, n. 2, p. 512, doi. 10.1002/cncr.10222
- By:
- Publication type:
- Article
Cyclic thrombocytopenia successfully treated with low dose hormonal contraception.
- Published in:
- American Journal of Hematology, 1995, v. 48, n. 1, p. 62, doi. 10.1002/ajh.2830480117
- By:
- Publication type:
- Article
Peptide Vaccination Against PD-L1 With IO103 a Novel Immune Modulatory Vaccine in Multiple Myeloma: A Phase I First-in-Human Trial.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.595035
- By:
- Publication type:
- Article
The Danish National Multiple Myeloma Registry.
- Published in:
- Clinical Epidemiology, 2016, v. 8, p. 583, doi. 10.2147/CLEP.S99463
- By:
- Publication type:
- Article
Incidence and clinical characteristics of multiple myeloma with low M-protein levels and normal values of hemoglobin, creatinine, calcium, and serum free light chain ratio.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 521, doi. 10.1002/hon.2906
- By:
- Publication type:
- Article
Causes of early death in multiple myeloma patients treated with high-dose therapy followed by autologous stem cell transplantation: A study based on the nationwide Danish Multiple Myeloma Registry.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 10, p. E611, doi. 10.1002/ajh.24857
- By:
- Publication type:
- Article
Causes of early death in multiple myeloma patients who are ineligible for high-dose therapy with hematopoietic stem cell support: A study based on the nationwide Danish Myeloma Database.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 4, p. E73, doi. 10.1002/ajh.23932
- By:
- Publication type:
- Article
Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission - results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Relationship between reasons for intermittent missing patient-reported outcomes data and missing data mechanisms.
- Published in:
- Quality of Life Research, 2024, v. 33, n. 9, p. 2387, doi. 10.1007/s11136-024-03707-y
- By:
- Publication type:
- Article
Strategies to improve patient-reported outcome completion rates in longitudinal studies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The real‐world use and efficacy of pomalidomide for relapsed and refractory multiple myeloma in the era of CD38 antibodies.
- Published in:
- EJHaem, 2023, v. 4, n. 4, p. 1006, doi. 10.1002/jha2.774
- By:
- Publication type:
- Article
Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population.
- Published in:
- PLoS ONE, 2017, v. 12, n. 12, p. 1, doi. 10.1371/journal.pone.0188988
- By:
- Publication type:
- Article